F. N. Biteghe

CD8+ T-cell immune escape by SARS-CoV-2 variants of concern

Arnaud John Kombe Kombe, Tengchuan Jin, F. N. Biteghe, 2022, Frontiers in Immunology.

Treatment of Chikungunya Virus (CHIKV) Using Targeted Immunotherapy

Jean de la Croix Ndong, Neelakshi Mungra, Arnaud John Kombe Kombe, 2021, Infectious Diseases.

Desensitization of metastatic melanoma cells to therapeutic treatment through repeated exposure to dacarbazine.

S. Barth, E. Padayachee, L. Davids, 2020, Journal of photochemistry and photobiology. B, Biology.

Human Antibody Fusion Proteins/Antibody Drug Conjugates in Breast and Ovarian Cancer

S. Barth, E. Padayachee, D. Bauerschlag, 2017, Transfusion Medicine and Hemotherapy.

Synergistic effects of radiotherapy and targeted immunotherapy in improving tumor treatment efficacy: a review

Jean de la Croix Ndong, Fleury Augustin Nsole Biteghe, Nyangone Ekome Toung Chalomie, 2022, Clinical and Translational Oncology.

Advances in epidermal growth factor receptor specific immunotherapy: lessons to be learned from armed antibodies

S. Barth, E. Padayachee, J. Engohang-Ndong, 2020, Oncotarget.

Antibody-Based Immunotherapy: Alternative Approaches for the Treatment of Metastatic Melanoma

S. Barth, A. Okem, G. Vignaux, 2020, Biomedicines.

Click Chemistry-Generated Auristatin F–Linker–Benzylguanine for a SNAP-Tag-Based Recombinant Antibody–Drug Conjugate Demonstrating Selective Cytotoxicity toward EGFR-Overexpressing Tumor Cells

S. Barth, D. Lang, W. Richter, 2023, ACS Omega.

Antibody Based Targeted Interventions for the Diagnosis and Treatment of Skin Cancers.

S. Barth, H. Adeola, Neelakshi Mungra, 2020, Anti-cancer agents in medicinal chemistry.

CSPG4 as a target for the specific killing of triple-negative breast cancer cells by a recombinant SNAP-tag-based antibody-auristatin F drug conjugate

S. Barth, D. Lang, S. Chetty, 2023, Journal of Cancer Research and Clinical Oncology.